Biotech SF
San Francisco Bay Area biotech stories.
Monday, January 31, 2011
Douglas Rosenberg invests $3.5M toward Alzheimer's drug development at Buck Institute
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment